Stay updated on Clinical Trial of HS-10382 in Chronic Myeloid Leukemia
Sign up to get notified when there's something new on the Clinical Trial of HS-10382 in Chronic Myeloid Leukemia page.

Latest updates to the Clinical Trial of HS-10382 in Chronic Myeloid Leukemia page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe page now displays the ClinicalTrials.gov record for a Phase 1 study of HS-10382 in patients with chronic myeloid leukemia, including study design, eligibility criteria, outcome measures, and a recruiting site in Wuhan, China.SummaryDifference51%

- Check18 days agoChange DetectedThe footer’s displayed site revision changes from v3.7.2 to v3.8.0; the page still shows a 403 Forbidden error instead of the study record.SummaryDifference0.2%

- Check25 days agoChange DetectedA sitewide notice announces an NIH transition from the term “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.SummaryDifference1%

- Check32 days agoChange DetectedThe revision number in the ClinicalTrials.gov page footer changed from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check39 days agoChange DetectedThe footer’s displayed site revision changes from v3.7.0 to v3.7.1; the page still shows a 403 Forbidden error.SummaryDifference0.2%

- Check53 days agoChange DetectedThe page now displays a 403 Forbidden error instead of the study record, indicating blocked access to the content. The surrounding header and footer are still visible around the error message.SummaryDifference0.5%

Stay in the know with updates to Clinical Trial of HS-10382 in Chronic Myeloid Leukemia
Enter your email address, and we'll notify you when there's something new on the Clinical Trial of HS-10382 in Chronic Myeloid Leukemia page.